Magyar Endokrinológiai és Anyagcsere Társaság VII. Endokrinológiai Továbbképző Tanfolyam (Budapest, 2011.12.02-03.)
Rendezvény kezdete: 2011.12.02.Rendezvény vége: 2011.12.03. Szakterület(ek): Belgyógyászat, Endokrinológia, anyagcsere betegségek
Helyszín: 1088 Budapest, Rákóczi út 43-45., Novotel Budapest Centrum A rendezvény Web oldala: http://www.convention.hu/rendezvenyek.php?page=confpage&id=336&subpage=482 A VII. Endokrinológiai Továbbképző Tanfolyam
a Magyar Endokrinológiai és Anyagcsere Társaság és a Semmelweis Egyetem II. sz. Belgyógyászati Klinika együttműködésével Budapesten, a Novotel Budapest Centrumban**** (1088 Budapest, Rákóczi út 43-45.) kerül megrendezésre, 2011. december 2-3-án.
AKKREDITÁCIÓ
A továbbképzés SE-TK/2011.II/00397 sorszámon - belgyógyászat és endokrinológia szakvizsgákhoz - kötelezően választható tanfolyamként került akkreditálásra, sikeres tesztírás esetén 40 kreditpont szerezhető.
FŐ TÉMÁK
”State of Art” előadás
A Klinefelter szindróma klinikuma és korszerű kezelése
Csilla Krausz (University of Florence, Italy)
Ipsen Szimpózium
Understanding the 2010 ACR guideline via interactive case discussions
Sebastian Neggers (Erasmus University, The Netherlands)
Andrológia
Férfi infertilitás
Férfi hypogonadismus
Endokrin krízisállapotok
Hypadrenia
Hypertoniás krizis
Hypoglykaemia
Hypophysis apoplexia
Thyreotoxicosis
Terápiás up-to-date
Transzszexualizmus
Neuroendokrin daganatok
Endokrin ophthalmopathia
Leggyakoribb endokrin problémák a mindennapi gyakorlatban: a családorvos és endokrinológus együttműködése
Pajzsmirigy göb
Menstruációs zavar/infertilitás
Hyperandrogenismus
Endokrin hypertonia gyanú
Elhízás
Serdülés zavarai
Komparativ endokrinológia
Tanulságos endokrin esetek
Esetmegbeszélés
Endokrinológia és művészet
Endokrinológia a művészetben
Az endokrinológia művésze
A művész endokrinológus
TUDOMÁNYOS INFORMÁCIÓ:
Prof. Dr. Rácz Károly egyetemi tanár
Semmelweis Egyetem Általános Orvostudományi Kar
II. sz. Belgyógyászati Klinika
* H-1088 Budapest, Szentkirályi u. 46
(Tel:06-1-266-0926, fax: 06-1-266-0816
E-mail: racz@bel2.sote.hu
KONGRESSZUSI IRODA
Lukácsi Máté
Convention Budapest Kft.
* H-1461 Budapest, Pf: 11.
(Tel: 06-1-299-0184, -85, -86, fax: 06-1-299-0187
E-mail: mlukacsi@convention.hu
További részletek és on-line regisztráció a rendezvény weboldalán: www.convention.hu >>
A program letölthető ide kattintva >> Kapcsolódó dokumentumok (1)
Magyar Nephrologiai Társaság New Era of Drug Discovery and Clinical Trials in Kidney Disease
Rendezvény kezdete: 2014.04.03.Rendezvény vége: 2014.04.06. Szakterület(ek): Nephrologia
Helyszín: Olaszország, Bergamo, A rendezvény Web oldala: http://www.isnnexus.org/bergamo ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
Magyar Nephrologiai Társaság New Era of Drug Discovery and Clinical Trials in Kidney Disease
Rendezvény kezdete: 2014.04.03.Rendezvény vége: 2014.04.06. Szakterület(ek): Nephrologia
Helyszín: Olaszország, Bergamo, A rendezvény Web oldala: http://www.isnnexus.org/bergamo ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
Magyar Nephrologiai Társaság New Era of Drug Discovery and Clinical Trials in Kidney Disease
Rendezvény kezdete: 2014.04.03.Rendezvény vége: 2014.04.06. Szakterület(ek): Nephrologia
Helyszín: Olaszország, Bergamo, A rendezvény Web oldala: http://www.isnnexus.org/bergamo ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.